THE ROLE OF NHS ENGLAND COMMISSIONING POLICIES IN PROMOTING EQUITABLE ACCESS TO HIGH-COST DRUGS

被引：0
|
作者：
Anderson, Marina [1 ]
机构：
[1] Univ Liverpool, Univ Hosp Aintree, Dept Rheumatol, Liverpool L69 3BX, Merseyside, England
来源：
RHEUMATOLOGY | 2015年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I69
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] INEQUITY IN CLINICAL COMMISSIONING GROUP FUNDING ACROSS ENGLAND FOR HIGH-COST BIOLOGIC DRUGS IN RHEUMATOID ARTHRITIS
    Buckeldee, Olivia
    Khanna, Rajakshi
    Snell, Laura
    Attipoe, Laura
    RHEUMATOLOGY, 2023, 62
  • [2] Trends and variation in issuance of high-cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022
    van Someren, Frederick
    Wiedemann, Milan
    Warren-Gash, Charlotte
    Sykorova, Martina
    Mistry, Hema
    Miller, Michelle A.
    Leschziner, Guy
    Nolte, Ellen
    Belot, Aurelien
    Smith, Ian E.
    Quinnell, Tim
    Eriksson, Sofia H.
    Strongman, Helen
    JOURNAL OF SLEEP RESEARCH, 2024,
  • [3] NHS England commissioning for value: what is the hidden cost?
    Okecha, E.
    Barry, O.
    Johnston, A.
    Mellor, J.
    Baker, H.
    Lee, V.
    HIV MEDICINE, 2018, 19 : S5 - S5
  • [4] Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund
    Aggarwal, A.
    Fojo, T.
    Chamberlain, C.
    Davis, C.
    Sullivan, R.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1738 - 1750
  • [5] THE NOT-NICE ACCESS PATHWAY: NHS ENGLAND SPECIALISED COMMISSIONING
    Roibu, C.
    Ivanova, H.
    Macaulay, R.
    VALUE IN HEALTH, 2019, 22 : S799 - S799
  • [6] OPPORTUNITIES FOR HIGH-COST DRUGS IN INDIA
    Ramabadran, A.
    Samuel, J. J.
    Edathodu, A.
    Mukku, S. R.
    VALUE IN HEALTH, 2017, 20 (05) : A131 - A131
  • [7] Access to high-cost drugs for rare diseases in Brazil: mucopolysaccharidosis Type I
    Boy, R.
    Krug, B.
    Gialdi, O.
    Santana-da-Silva, L. C.
    Steiner, C.
    Acosta, A. X.
    Ribeiro, E. M.
    Galera, M. F.
    Leivas, P. G. C.
    Braz, M.
    Schwartz, I. V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S69 - S69
  • [8] Improving access to high-cost cancer drugs in Latin America: Much to be done
    Ruiz, Rossana
    Strasser-Weippl, Kathrin
    Touya, Diego
    Herrero Vincent, Carmen
    Hernandez-Blanquisett, Abraham
    St Louis, Jessica
    Bukowski, Alexandra
    Goss, Paul E.
    CANCER, 2017, 123 (08) : 1313 - 1323
  • [9] IMPACT OF HEALTH TECHNOLOGY ASSESSMENT IN LITIGATION CONCERNING ACCESS TO HIGH-COST DRUGS
    Aleman, Alicia
    Galan, Ana Perez
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (04) : 411 - 414
  • [10] Access to high-cost drugs in Brazil from the perspective of physicians, pharmacists and patients
    Mattozo Rover, Marina Raijche
    Vargas-Pelaez, Claudia Marcela
    Farias, Mareni Rocha
    Leite, Silvana Nair
    GACETA SANITARIA, 2016, 30 (02) : 110 - 116
12345